Merck Inc. receives positive CHMP opinion for expanded approval of Keytruda in certain patients with relapsed or refractory classical Hodgkin lymphoma
Merck announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of an expanded… read more.